19 Promis Title serves as Executive at ProMIS Neurosciences Inc., where they oversee executive responsibilities. Since joining the company, 19 Promis Title has executed 5 insider transactions totaling $0, demonstrating a balanced approach to their equity position. Their most recent transaction on Jul 25, 2025 involved exercising options for 119,800 shares valued at $0.
19 Promis Title currently holds 2,435,029 shares of ProMIS Neurosciences Inc. (PMN), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, 19 Promis Title has been a net neutral trader of PMN stock. They have purchased $0 and sold $0 worth of shares.
19 Promis Title's most recent insider trade was on Jul 25, 2025, when they sold 119,800 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $N/A |
| Discretionary |
| Jul 25, 2025 | PMN | $0 | Exercise | 119,800 | $N/A | Discretionary |
| Jul 31, 2024 | PMN | $0 | Purchase | 465,116 | $N/A | Discretionary |
| Jul 31, 2024 | PMN | $0 | Conversion | 500,000 | $N/A | Discretionary |